NEW YORK - An experimental gel managed to prevent some of the female monkeys infected with the AIDS virus, according to results of tests conducted a number of scientists who are members of the Population Council.
The test itself is conducted to mimic the path of transmission through sexual intercourse in humans. Gel is using AIDS drugs and zinc components, managed to prevent all animals tested from the HIV virus for the monkey. The result itself has been reported in the journal Public Library of Science.
As reported by Straits Times, Thursday (6/1/20110, gel experiments were able to provide protection of 21 female monkeys in the next 24 hours. That's after they received a dose of gel every day for two weeks.
Drugs used in the gel are so few that its safety is assured. Also the price was estimated reasonably priced.
Melissa Robbiani, one member of the Population Council, who also worked with the National Cancer Institute and several other laboratories to test the gel, hoping to soon conduct trials in humans.
The results of this study is actually not the first time. Last July scientists created AIDS was surprised when a number of scientists found a similar gel containing tenofovir and Gilead AIDS drug has reduced transmission rates in women up to 39 percent for 2.5 years.
The test itself is conducted to mimic the path of transmission through sexual intercourse in humans. Gel is using AIDS drugs and zinc components, managed to prevent all animals tested from the HIV virus for the monkey. The result itself has been reported in the journal Public Library of Science.
As reported by Straits Times, Thursday (6/1/20110, gel experiments were able to provide protection of 21 female monkeys in the next 24 hours. That's after they received a dose of gel every day for two weeks.
Drugs used in the gel are so few that its safety is assured. Also the price was estimated reasonably priced.
Melissa Robbiani, one member of the Population Council, who also worked with the National Cancer Institute and several other laboratories to test the gel, hoping to soon conduct trials in humans.
The results of this study is actually not the first time. Last July scientists created AIDS was surprised when a number of scientists found a similar gel containing tenofovir and Gilead AIDS drug has reduced transmission rates in women up to 39 percent for 2.5 years.